The Role of Micronutrients in Heart Failure

Journal of the Academy of Nutrition and Dietetics

Volumn 112, Issue 6, 2012, Pages 870-886

  McKeag, Nicholas A ^a   McKinley, Michelle C ^a   Woodside, Jayne V ^a   Harbinson, Mark T ^a   McKeown, Pascal P ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Heart failure; Micronutrient; Nutrition

Indexed keywords

HOMOCYSTEINE; MINERAL; TRACE ELEMENT; VITAMIN;

ARTICLE; CHRONIC DISEASE; DIET THERAPY; HEART FAILURE; HUMAN; METABOLISM; NUTRITION; NUTRITIONAL STATUS; PHYSIOLOGY; PROGNOSIS;

CHRONIC DISEASE; HEART FAILURE; HOMOCYSTEINE; HUMANS; MICRONUTRIENTS; MINERALS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; NUTRITIONAL STATUS; PROGNOSIS; VITAMINS;

EID: 84861368684     PISSN: 22122672     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jand.2012.01.016     Document Type: Article

References (104)

1. Dickstein K., Cohen-Solal A., Filippatos G., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008, 10(10):933-989.
2. Lloyd-Jones D.M., Larson M.G., Leip E.P., et al. Lifetime risk for developing congestive heart failure: The Framingham Heart Study. Circulation 2002, 106(24):3068-3072.
3. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation 2011, 123(4):e18-e209.
4. Lloyd-Jones D., Adams R.J., Brown T.M., et al. Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 2010, 121(7):e46-e215.
5. Levy D., Kenchaiah S., Larson M.G., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002, 347(18):1397-1402.
6. Anker S.D., Ponikowski P., Varney S., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997, 349(9058):1050-1053.
7. von Haehling S., Doehner W., Anker S.D. Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res 2007, 73(2):298-309.
8. Woodside J.V., McCall D., McGartland C., Young I.S. Micronutrients: Dietary intake v. supplement use. Proc Nutr Soc 2005, 64(4):543-553.
9. Evans P., Halliwell B. Micronutrients: Oxidant/antioxidant status. Br J Nutr 2001, 85(suppl 2):S67-S74.
10. Li Y.C., Qiao G., Uskokovic M., Xiang W., Zheng W., Kong J. Vitamin D: A negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004, 89-90(1-5):387-392.
11. Jessup M., Abraham W.T., Casey D.E., et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009, 119(14):1977-2016.
12. Lindenfeld J., Albert N.M., et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail 2010, 16(6):e1-e194. Heart Failure Society of America.
13. Soukoulis V., Dihu J.B., Sole M., et al. Micronutrient deficiencies an unmet need in heart failure. J Am Coll Cardiol 2009, 54(18):1660-1673.
14. de Lorgeril M., Salen P., Accominotti M., et al. Dietary and blood antioxidants in patients with chronic heart failure. Insights into the potential importance of selenium in heart failure. Eur J Heart Fail 2001, 3(6):661-669.
15. Gorelik O., Almoznino-Sarafian D., Feder I., et al. Dietary intake of various nutrients in older patients with congestive heart failure. Cardiology 2003, 99(4):177-181.
16. Price R.J., Witham M.D., McMurdo M.E. Defining the nutritional status and dietary intake of older heart failure patients. Eur J Cardiovasc Nurs 2007, 6(3):178-183.
17. Catapano G., Pedone C., Nunziata E., Zizzo A., Passantino A., Incalzi R.A. Nutrient intake and serum cytokine pattern in elderly people with heart failure. Eur J Heart Fail 2008, 10(4):428-434.
18. Arcand J., Floras V., Ahmed M., et al. Nutritional inadequacies in patients with stable heart failure. J Am Diet Assoc 2009, 109(11):1909-1913.
19. Lourenco B.H., Vieira L.P., Macedo A., et al. Nutritional status and adequacy of energy and nutrient intakes among heart failure patients. Arq Bras Cardiol 2009, 93(5):541-548.
20. Lemon S.C., Olendzki B., Magner R., et al. The dietary quality of persons with heart failure in NHANES 1999-2006. J Gen Intern Med 2010, 25(2):135-140.
21. Hughes C.M., Woodside J.V., McGartland C., Roberts M.J., Nicholls D.P., McKeown P.P. Nutritional intake and oxidative stress in chronic heart failure. Nutr Metab Cardiovasc Dis 2012, 22(4):376-382.
22. Keith M., Geranmayegan A., Sole M.J., et al. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 1998, 31(6):1352-1356.
23. Demirbag R., Yilmaz R., Erel O., Gultekin U., Asci D., Elbasan Z. The relationship between potency of oxidative stress and severity of dilated cardiomyopathy. Can J Cardiol 2005, 21(10):851-855.
24. Remme W.J., Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001, 22(17):1527-1560. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology.
25. Hornig B., Arakawa N., Kohler C., Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998, 97(4):363-368.
26. Patel S., Celermajer D.S. Assessment of vascular disease using arterial flow mediated dilatation. Pharmacol Rep 2006, 58(suppl):3-7.
27. Ellis G.R., Anderson R.A., Lang D., et al. Neutrophil superoxide anion-Generating capacity, endothelial function and oxidative stress in chronic heart failure: Effects of short- and long-term vitamin C therapy. J Am Coll Cardiol 2000, 36(5):1474-1482.
28. Ellis G.R., Anderson R.A., Chirkov Y.Y., et al. Acute effects of vitamin C on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failure. J Cardiovasc Pharmacol 2001, 37(5):564-570.
29. Erbs S., Gielen S., Linke A., et al. Improvement of peripheral endothelial dysfunction by acute vitamin C application: Different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy. Am Heart J 2003, 146(2):280-285.
30. Piccirillo G., Nocco M., Moise A., et al. Influence of vitamin C on baroreflex sensitivity in chronic heart failure. Hypertension 2003, 41(6):1240-1245.
31. Mak S., Overgaard C.B., Newton G.E. Effect of vitamin C and L-NMMA on the inotropic response to dobutamine in patients with heart failure. Am J Physiol Heart Circ Physiol 2005, 289(6):H2424-H2428.
32. Shinke T., Shite J., Takaoka H., et al. Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction. Am Heart J 2007, 154(4):645.e1-645.e8.
33. Ghatak A., Brar M.J., Agarwal A., et al. Oxy free radical system in heart failure and therapeutic role of oral vitamin E. Int J Cardiol 1996, 57(2):119-127.
34. Ho K.K., Pinsky J.L., Kannel W.B., Levy D. The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol 1993, 22(4 suppl A):6A-13A.
35. Yusuf S., Dagenais G., Pogue J., Bosch J., Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000, 342(3):154-160.
36. Lonn E., Bosch J., Yusuf S., et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: A randomized controlled trial. JAMA 2005, 293(11):1338-1347.
37. Marchioli R., Levantesi G., Macchia A., et al. Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial. J Cardiovasc Med (Hagerstown) 2006, 7(5):347-350.
38. Keith M.E., Jeejeebhoy K.N., Langer A., et al. A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. Am J Clin Nutr 2001, 73(2):219-224.
39. Mendoza C.E., Rodriguez F., Rosenberg D.G. Reversal of refractory congestive heart failure after thiamine supplementation: Report of a case and review of literature. J Cardiovasc Pharmacol Ther 2003, 8(4):313-316.
40. Seligmann H., Halkin H., Rauchfleisch S., et al. Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: A pilot study. Am J Med 1991, 91(2):151-155.
41. Kwok T., Falconer-Smith J.F., Potter J.F., Ives D.R. Thiamine status of elderly patients with cardiac failure. Age Ageing 1992, 21(1):67-71.
42. Pfitzenmeyer P., Guilland J.C., d'Athis P., Petit-Marnier C., Gaudet M. Thiamine status of elderly patients with cardiac failure including the effects of supplementation. Int J Vitam Nutr Res 1994, 64(2):113-118.
43. Brady J.A., Rock C.L., Horneffer M.R. Thiamin status, diuretic medications, and the management of congestive heart failure. J Am Diet Assoc 1995, 95(5):541-544.
44. Yue Q.Y., Beermann B., Lindstrom B., Nyquist O. No difference in blood thiamine diphosphate levels between Swedish Caucasian patients with congestive heart failure treated with furosemide and patients without heart failure. J Intern Med 1997, 242(6):491-495.
45. da Cunha S., Albanesi Filho F.M., da Cunha Bastos V.L., Antelo D.S., Souza M.M. Thiamin, selenium, and copper levels in patients with idiopathic dilated cardiomyopathy taking diuretics. Arq Bras Cardiol 2002, 79(5):454-465.
46. Zenuk C., Healey J., Donnelly J., Vaillancourt R., Almalki Y., Smith S. Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy. Can J Clin Pharmacol 2003, 10(4):184-188.
47. Hanninen S.A., Darling P.B., Sole M.J., Barr A., Keith M.E. The prevalence of thiamin deficiency in hospitalized patients with congestive heart failure. J Am Coll Cardiol 2006, 47(2):354-361.
48. Abou-Hashem R.M., Maamoun M.M., Hamza S.A., Fahmy H.M., Mortagy A.K. Thiamine level in hospitalized elderly Egyptian patients with congestive heart failure and left ventricular systolic dysfunction. J Am Geriatr Soc 2009, 57(11):2165-2166.
49. Shimon I., Almog S., Vered Z., et al. Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. Am J Med 1995, 98(5):485-490.
50. Keith M.E., Walsh N.A., Darling P.B., et al. B-vitamin deficiency in hospitalized patients with heart failure. J Am Diet Assoc 2009, 109(8):1406-1410.
51. Herzlich B.C., Lichstein E., Schulhoff N., et al. Relationship among homocyst(e)ine, vitamin B-12 and cardiac disease in the elderly: Association between vitamin B-12 deficiency and decreased left ventricular ejection fraction. J Nutr 1996, 126(4 suppl):1249S-1253S.
52. Herrmann M., Muller S., Kindermann I., et al. Plasma B vitamins and their relation to the severity of chronic heart failure. Am J Clin Nutr 2007, 85(1):117-123.
53. Daniels L.B., Maisel A.S. Natriuretic peptides. J Am Coll Cardiol 2007, 50(25):2357-2368.
54. Witte K.K., Desilva R., Chattopadhyay S., Ghosh J., Cleland J.G., Clark A.L. Are hematinic deficiencies the cause of anemia in chronic heart failure?. Am Heart J 2004, 147(5):924-930.
55. Andersson S.E., Edvinsson M.L., Edvinsson L. Reduction of homocysteine in elderly with heart failure improved vascular function and blood pressure control but did not affect inflammatory activity. Basic Clin Pharmacol Toxicol 2005, 97(5):306-310.
56. Shane E., Mancini D., Aaronson K., et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 1997, 103(3):197-207.
57. Pilz S., Marz W., Wellnitz B., et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008, 93(10):3927-3935.
58. Zittermann A., Schleithoff S.S., Tenderich G., Berthold H.K., Korfer R., Stehle P. Low vitamin D status: A contributing factor in the pathogenesis of congestive heart failure?. J Am Coll Cardiol 2003, 41(1):105-112.
59. Zittermann A., Schleithoff S.S., Gotting C., et al. Poor outcome in end-stage heart failure patients with low circulating calcitriol levels. Eur J Heart Fail 2008, 10(3):321-327.
60. Ameri P., Ronco D., Casu M., et al. High prevalence of vitamin D deficiency and its association with left ventricular dilation: An echocardiography study in elderly patients with chronic heart failure. Nutr Metab Cardiovasc Dis 2010, 20(9):633-640.
61. Iqbal N., Ducharme J., Desai S., et al. Status of bone mineral density in patients selected for cardiac transplantation. Endocr Pract 2008, 14(6):704-712.
62. Alsafwah S., Laguardia S.P., Nelson M.D., et al. Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure. Am J Med Sci 2008, 335(4):292-297.
63. Arroyo M., Laguardia S.P., Bhattacharya S.K., et al. Micronutrients in African-Americans with decompensated and compensated heart failure. Transl Res 2006, 148(6):301-308.
64. Laguardia S.P., Dockery B.K., Bhattacharya S.K., Nelson M.D., Carbone L.D., Weber K.T. Secondary hyperparathyroidism and hypovitaminosis D in African-Americans with decompensated heart failure. Am J Med Sci 2006, 332(3):112-118.
65. Abou-Raya S., Abou-Raya A. Osteoporosis and congestive heart failure (CHF) in the elderly patient: Double disease burden. Arch Gerontol Geriatr 2009, 49(2):250-254.
66. Garakyaraghi M., Kerdegari M., Siavash M. Calcium and vitamin D status in heart failure patients in Isfahan, Iran. Biol Trace Elem Res 2010, 135(1-3):67-73.
67. Kim D.H., Sabour S., Sagar U.N., Adams S., Whellan D.J. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol 2008, 102(11):1540-1544.
68. Anderson J.L., May H.T., Horne B.D., et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010, 106(7):963-968.
69. Bolland M.J., Bacon C.J., Horne A.M., et al. Vitamin D insufficiency and health outcomes over 5 y in older women. Am J Clin Nutr 2010, 91(1):82-89.
70. Boxer R.S., Dauser D.A., Walsh S.J., Hager W.D., Kenny A.M. The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure. J Am Geriatr Soc 2008, 56(3):454-461.
71. Boxer R.S., Kenny A.M., Cheruvu V.K., Vest M., Fiutem J.J., Pina I.I. Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure. Am Heart J 2010, 160(5):893-899.
72. McGonigle R.J., Timmis A.D., Keenan J., Jewitt D.E., Weston M.J., Parsons V. The influence of 1 alpha-hydroxycholecalciferol on left ventricular function in end-stage renal failure. Proc Eur Dial Transplant Assoc 1981, 18:579-585.
73. Schleithoff S.S., Zittermann A., Tenderich G., Berthold H.K., Stehle P., Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: A double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006, 83(4):754-759.
74. Witham M.D., Crighton L.J., Gillespie N.D., Struthers A.D., McMurdo M.E. The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: A randomized controlled trial. Circ Heart Fail 2010, 3(2):195-201.
75. Hsia J., Heiss G., Ren H., et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007, 115(7):846-854.
76. Vieth R. Vitamin D toxicity, policy, and science. J Bone Miner Res 2007, 22(suppl 2):V64-V68.
77. Edelson G.W., Kleerekoper M. Hypercalcemic crisis. Med Clin North Am 1995, 79(1):79-92.
78. Lowe H., Cusano N.E., Binkley N., Blaner W.S., Bilezikian J.P. Vitamin D toxicity due to a commonly available "over the counter" remedy from the Dominican Republic. J Clin Endocrinol Metab 2011, 96(2):291-295.
79. Dietary Reference Intakes for Calcium and Vitamin D 2011, National Academies Press, Washington, DC. A.C. Ross, C.L. Taylor, A.L. Yaktine, H.B. Del Valle (Eds.).
80. Ge K., Yang G. The epidemiology of selenium deficiency in the etiological study of endemic diseases in China. Am J Clin Nutr 1993, 57(2 suppl):259S-263S.
81. Oster O., Prellwitz W., Kasper W., Meinertz T. Congestive cardiomyopathy and the selenium content of serum. Clin Chim Acta 1983, 128(1):125-132.
82. Cenac A., Simonoff M., Djibo A. Nutritional status and plasma trace elements in peripartum cardiomyopathy. A comparative study in Niger. J Cardiovasc Risk 1996, 3(6):483-487.
83. Chou H.T., Yang H.L., Tsou S.S., Ho R.K., Pai P.Y., Hsu H.B. Status of trace elements in patients with idiopathic dilated cardiomyopathy in central Taiwan. Zhonghua Yi Xue Za Zhi (Taipei) 1998, 61(4):193-198.
84. Navarro-Alarcon M., Lopez-Garcia de la Serrana H., Perez-Valero V., Lopez-Martinez C. Serum and urine selenium concentrations in patients with cardiovascular diseases and relationship to other nutritional indexes. Ann Nutr Metab 1999, 43(1):30-36.
85. Raines D.A., Kinsara A.J., Eid Fawzy M., et al. Plasma and urinary selenium in Saudi Arabian patients with dilated cardiomyopathy. Biol Trace Elem Res 1999, 69(1):59-68.
86. Kosar F., Sahin I., Taskapan C., et al. Trace element status (Se, Zn, Cu) in heart failure. Anadolu Kardiyol Derg 2006, 6(3):216-220.
87. Oster O. Trace element concentrations (Cu, Zn, Fe) in sera from patients with dilated cardiomyopathy. Clin Chim Acta 1993, 214(2):209-218.
88. Golik A., Cohen N., Ramot Y., et al. Type II diabetes mellitus, congestive heart failure, and zinc metabolism. Biol Trace Elem Res 1993, 39(2-3):171-175.
89. Ripa S., Ripa R., Giustiniani S. Are failured cardiomyopathies a zinc-deficit related disease?. A study on Zn and Cu in patients with chronic failured dilated and hypertrophic cardiomyopathies. Minerva Med 1998, 89(11-12):397-403.
90. Topuzoglu G., Erbay A.R., Karul A.B., Yensel N. Concentrations of copper, zinc, and magnesium in sera from patients with idiopathic dilated cardiomyopathy. Biol Trace Elem Res 2003, 95(1):11-17.
91. Salehifar E., Shokrzadeh M., Ghaemian A., Aliakbari S., Saeedi Saravi S.S. The study of Cu and Zn serum levels in idiopathic dilated cardiomyopathy (IDCMP) patients and its comparison with healthy volunteers. Biol Trace Elem Res 2008, 125(2):97-108.
92. Shokrzadeh M., Ghaemian A., Salehifar E., Aliakbari S., Saravi S.S., Ebrahimi P. Serum zinc and copper levels in ischemic cardiomyopathy. Biol Trace Elem Res 2009, 127(2):116-123.
93. Malek F., Dvorak J., Jiresova E., Spacek R. Difference of baseline serum copper levels between groups of patients with different one year mortality and morbidity and chronic heart failure. Cent Eur J Public Health 2003, 11(4):198-201.
94. Jeejeebhoy F., Keith M., Freeman M., et al. Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction. Am Heart J 2002, 143(6):1092-1100.
95. Witte K.K., Nikitin N.P., Parker A.C., et al. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J 2005, 26(21):2238-2244.
96. Lennie T.A., Moser D.K., Heo S., Chung M.L., Zambroski C.H. Factors influencing food intake in patients with heart failure: A comparison with healthy elders. J Cardiovasc Nurs 2006, 21(2):123-129.
97. King D., Smith M.L., Chapman T.J., Stockdale H.R., Lye M. Fat malabsorption in elderly patients with cardiac cachexia. Age Ageing 1996, 25(2):144-149.
98. Koren-Michowitz M., Dishy V., Zaidenstein R., et al. The effect of losartan and losartan/hydrochlorothiazide fixed-combination on magnesium, zinc, and nitric oxide metabolism in hypertensive patients: A prospective open-label study. Am J Hypertens 2005, 18(3):358-363.
99. Witte K.K., Clark A.L. Micronutrients and their supplementation in chronic cardiac failure. An update beyond theoretical perspectives. Heart Fail Rev 2006, 11(1):65-74.
100. Weber K.T., Weglicki W.B., Simpson R.U. Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium. Cardiovasc Res 2009, 81(3):500-508.
101. Nemerovski C.W., Dorsch M.P., Simpson R.U., Bone H.G., Aaronson K.D., Bleske B.E. Vitamin D and cardiovascular disease. Pharmacotherapy 2009, 29(6):691-708.
102. Review of the II Guidelines of the Sociedade Brasileira de Cardiologia for the diagnosis and treatment of heart failure. Arq Bras Cardiol 2002, 79(suppl 4):1-30. Sociedade Brasileira de Cardiologia.
103. Richardson P., McKenna W., Bristow M., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996, 93(5):841-842.
104. Goodwin J.F., Oakley C.M. The cardiomyopathies. Br Heart J 1972, 34(6):545-552.